Riskpilot← Back to searchSign inGet full accessGalena Pharma Oy
OYActiveY-tunnus 1057172-0Sammonkatu 10Manufacture of pharmaceutical preparations · NACE 2120Est. 199610 employees
Revenue 2024
EUR 0
EBITDA margin
—
-8% vs 2023
Equity ratio
57.5%
Financial strength
Net profit 2024
EUR 129K
+1% vs 2023
| Revenue | EUR 0 | — |
| EBITDA | EUR 766K | -8% |
| Net profit | EUR 129K | +1% |
| Total assets | EUR 5,2M | +13% |
| Equity | EUR 3M | +5% |
| Employees | 10 | — |
Legal name
Galena Pharma Oy
Y-tunnus number
1057172-0
Legal form
Osakeyhtiö
NACE code
2120 · Manufacture of pharmaceutical preparations
Founded
9. elokuuta 1996
Share capital
EUR 325 746
Employees
10 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on lääkkeiden, rohdos- ja ravintoainevalmisteiden sekä elintarvikkeiden ja teknokemian tuotteiden kehittäminen, valmistus, maahantuonti ja markkinointi sekä alaan liittyvien palvelujen tuottaminen ja konsultointi. Yhtiö voi toimintaansa varten omistaa ja hallita sekä vuokrata kiinteistöjä ja osakkeita.
Address
Sammonkatu 10
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 424 | 3 740 | 3 924 | 4 626 | 0 |
| Staff expenses | −1 488 | −1 681 | −1 903 | −2 111 | −2 182 |
| EBITDA | 1 883 | 774 | 766 | 831 | 766 |
| Depreciation & amort. | −540 | −301 | −321 | −356 | −425 |
| EBIT | 1 343 | 473 | 444 | 475 | 341 |
| Net financials | 3 | −0 | −0 | −0 | −0 |
| Profit before tax | 514 | 260 | 62 | 128 | 129 |
| Tax | 270 | 53 | 64 | 0 | −0 |
| Net profit | 244 | 207 | −1 | 128 | 129 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 330 | 3 751 | 4 520 | 4 591 | 5 194 |
| Equity | 2 523 | 2 901 | 3 000 | 2 856 | 2 986 |
| Long-term debt | — | 43 | 68 | 0 | 0 |
| Short-term debt | 807 | 807 | 1 452 | 1 332 | 1 756 |
| Total debt | 807 | 850 | 1 520 | 1 332 | 1 756 |
EBITDA margin
76561700.0%
This company
15.8%
Market median
+484567622% vs market
20202024
Equity ratio
57.5%
This company
38.2%
Market median
+51% vs market
20202024
Return on equity
4.3%
This company
18.4%
Market median
-77% vs market
20202024
Net profit margin
12935300.0%
This company
8.1%
Market median
+159694962% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
0.74×
This company
0.62×
Market median
+19% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PM Confidential Clerk | Confidential Clerk | 2026 |
HA Chief Executive Officer | Chief Executive Officer | 2023 |
| Former (2) | ||
AS Chief Executive Officer | Chief Executive Officer | 2011 – 2023 |
TJ Audit | Audit | 2017 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Board of Directors | 2025 | |
| Former (4) | ||
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2025 – 2025 | |
| Board of Directors | 2011 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
GPX Holding Oy
Galena Pharma Oy Board members of Galena Pharma Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Atte Samuli Kukkonen | Chief Executive Officer | 0 companies |
| Piritta Marianne Maunu | Confidential Clerk | 0 companies |
| Turo Juhani Koila | Audit | 0 companies |
| Hans Alexej von Bagh | Chief Executive Officer | 0 companies |
| Arjo Tapani Laukia | Board of Directors | 0 companies |
| Anna-Maria Tuokko | Board of Directors | 0 companies |
| Joel Kristoffer Sjölund | Board of Directors | 0 companies |
| Heidi Marjaana Taipale | Board of Directors | 0 companies |
| Mikko Pekka Kukkonen | Board of Directors | 0 companies |
| Teemu Tapani Vuorinen | Board of Directors | 0 companies |